Eva Morava-kozicz
Clinical trials sponsored by Eva Morava-kozicz, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a common supplement help a rare disease? early trial begins Results expected Aug 2027 (estimated)
-
Sugar supplement may calm seizures and stomach troubles in rare genetic disease
Disease control Not yet recruitingThis study tests whether a sugar called D-galactose (AVTX-801) can help people with SLC35A2-CDG, a rare inherited disorder that disrupts how the body adds sugar to proteins. The trial enrolls about 10 people of any age who have seizures or chronic digestive issues. Participants r…
Phase 2 • Sponsor: Eva Morava-Kozicz • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Sugar supplement shows promise for rare disease in new trial
Disease control Not yet recruitingThis phase 2b trial tests AVTX-801, a D-galactose supplement, in 8 adults with PGM1-CDG, a rare genetic disorder affecting sugar metabolism. Participants currently on D-galactose will receive either the study drug or a placebo to see if it reduces disease-related events like low …
Phase 2 • Sponsor: Eva Morava-Kozicz • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC